NCT03451890

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Eisai Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study will be conducted to evaluate the safety, tolerability, and pharmacokinetics of single ascending oral doses of E2730 in healthy adult participants.

Conditions

• Healthy Participants

Interventions

Type	Name	Description
DRUG	E2730	oral capsule
DRUG	Placebo	oral capsule

Timeline

• Start date: 2018-02-09
• Primary completion: 2018-09-26
• Completion: 2018-09-26
• First posted: 2018-03-02
• Last updated: 2019-03-04

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study